Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > EPS for 2016?
View:
Post by adamchess on Nov 26, 2015 2:11am

EPS for 2016?

 

Does anyone know this number? From the information below I could conclude it is $7.00

for example, nine months 2015, EBITDA of 146.8 million resulted in EPS of $3.14 and 2016 EBITDA of 640 million is more than 4 times 2015 9 months amount. thus 4 x $3.14 = $12.56

This would be lowered by higher interest cost of $5/sh and 25% more shares, so 2016 EPS is probably between $6 to $8. Where does that put CXR valuation? $140?? using multiple of 20 times

Home Depot trades at $135 US on expected 2015 EPS $5.36. A multiple of 25 times. CXR expected growth 2017 will dwarf HD percentage wise.


- A transformational quarter with strong performance by legacy business -

Third Quarter 2015 Highlights

  • Concordia announced its acquisition of Amdipharm Mercury Limited ("AMCo") for $3.3 billion 1.
  • Adjusted EBITDA2 of $71.7 million , growing 254 per cent versus the same period in 2014.
  • Adjusted EPSof $1.46 , growing 157 per cent over the third quarter in 2014.
  • Revenue growth of 161 per cent to $94.9 million compared to the third quarter of 2014.

 

2015 Nine Month Highlights

  • Revenue growth of 163 per cent to $208.9 million compared to the same period in 2014.
  • Adjusted EBITDA2 of $146.8 million , growing 280 per cent versus the same period in 2014.
  • Adjusted EPS2 of $3.14 a growth of 185 per cent versus the first nine months of 2014.

 

2016 Guidance Reaffirmed

  • Adjusted EBITDA2 of $610 million to $640 million .
Comment by CJAlberta on Nov 26, 2015 2:54am
This post has been removed in accordance with Community Policy
Comment by Lumberfeverlong on Nov 26, 2015 7:51am
Do these EPS numbers account for interest and principal paid on the debt?  In other words, is total cash left after interest and principal are paid based on their agreed amortization schedule?  If not, what are their net earnings numbers?
Comment by fdfd12 on Nov 26, 2015 8:01am
EPS is left and with that, they will pay the debt. If they paid the debt and were left with these numbers, then the stock would have been $1,000 NOW
Comment by Lumberfeverlong on Nov 26, 2015 8:07am
Thanks for the clarification.  So what are their quarterly interest and principal payments?
Comment by fdfd12 on Nov 26, 2015 8:28am
https://www.bnn.ca/Video/player.aspx?vid=739294 this should do it. Who better than the CEO to tell you all the info.
Comment by adamchess on Nov 26, 2015 10:08am
That is why I forecasted CXR is selling at least $400 in 5 years. Not sure if it gets there without being taken over. Do you like the stock options on this one for Apr 15? say $60 strike? If we go $65 by year end that would be a nice double or more also maybe.
Comment by fdfd12 on Nov 26, 2015 7:04am
Adjusted net income2 of US$330 million to US$355 million ; adjusted earnings per share (EPS)2, 3 of US$6.29 to US$6.77 Home Depot is in another field. They are not under attack by CLinton and don't have VRX dragging them down.
Comment by adamchess on Dec 06, 2015 3:53pm
Rehash from earlier post. Hope it helps.
Comment by sunshine7 on Dec 06, 2015 4:38pm
all you really need to know: Concordia 2015 3Q results without AMCo... Adjusted EBITDA2 of $71.7 million Adjusted EPS2 of $1.46, Revenue $94.9 million. Concordia results WITH AMCo: 2016 Guidance Reaffirmed Adjusted EBITDA2 of $610 million to $640 million; [total 2016 EPS2 should be $610/53(SOS)=$11.51 ... considering AMCo was almost 2xCXR before acquired, this may be conservative.
Comment by fdfd12 on Dec 06, 2015 4:55pm
What I see is AMCO will give CXR an additional $76US in profit for the year. This makes it 19M for each Q. We are doing without AMCO 51M in profit without them. I don't see this as double. Someone, please show me this as a double. Also 35M shares outstanding is now 51M.
Comment by sunshine7 on Dec 06, 2015 5:17pm
"additional $76US " plus $51 = $127M. That is more than double. Makes sense since AMCo was almost twice the size of Concordia. Don't confuse profit with EBITDA. I think investors focus on growth and EBITDA because that is what will pay for the investments.
Comment by Scruggstyle on Dec 06, 2015 7:11pm
There are many reasons that different valuation metrics are used to value different companies.  Be careful drawing conclusions, as valuation theory is complex, and there is no "one size fits all".  All prospective purchasers are interested in two basic things:  Expected future cas flows and the risk of achieving those cash flows.  Net Income is sometimes not used ...more  
Comment by healthstock1234 on Dec 06, 2015 11:16pm
new geographical exposure is excellent concerning country-risk and diversification but the company deals with many currencies and exchanges rates could have an positive/negative impact also.  The conso financial statements were converted, the exchange rate could be different in time.
Comment by sunshine7 on Dec 06, 2015 11:17pm
They have hedges in place. Not an issue.
Comment by fdfd12 on Dec 06, 2015 9:04pm
Sunny dead wrong. That $76m is for the whole year of 2014. That means $19M for each Q. That means 19M plus our 51M=70M for each Q divided by 51M shares is 70/51= $1.40 EPS. Guys please tell me that I am wrong.
Comment by sunshine7 on Dec 06, 2015 11:27pm
Thought I would bring this to the top of the pile of theories... from the latest financial report. No extrapolation needed...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities